Publicacions en col·laboració amb investigadors/es de Dalhousie University (27)

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  2. Model-interpreted outcomes of artificial neural networks classifying immune biomarkers associated with severe infections in ICU

    Frontiers in Immunology, Vol. 14

  3. Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients

    Expert Review of Anti-Infective Therapy, Vol. 21, Núm. 10, pp. 1135-1141

2022

  1. Alpha, Beta, Delta, Omicron, and SARS-CoV-2 Breakthrough Cases: Defining Immunological Mechanisms for Vaccine Waning and Vaccine-Variant Mismatch

    Frontiers in Virology, Vol. 2

  2. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

  3. Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

    Blood, Vol. 140, Núm. 21, pp. 2248-2260

2021

  1. Combining immunomodulators and antivirals for COVID-19 – Authors' reply

    The Lancet Microbe

  2. Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

    European Journal of Clinical Investigation, Vol. 51, Núm. 6

  3. Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 542-552

  4. Global impact of COVID-19 on stroke care

    International Journal of Stroke, Vol. 16, Núm. 5, pp. 573-584

  5. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  6. Mounting evidence of impaired viral control in severe COVID-19

    The Lancet Microbe

2020

  1. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation

    Journal of Infection in Developing Countries, Vol. 14, Núm. 3, pp. 265-267

  2. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction

    Cardiovascular research, Vol. 116, Núm. 10, pp. e132-e133

  3. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection

    Journal of Infection

  4. Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

    The Lancet, Vol. 396, Núm. 10262, pp. 1563-1573

  5. Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

    The Lancet Haematology, Vol. 7, Núm. 5, pp. e370-e380

  6. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2019

  1. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

    The Lancet Neurology, Vol. 18, Núm. 1, pp. 46-55

2017

  1. Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci

    Nature Genetics, Vol. 49, Núm. 7, pp. 993-1004